NCT06907069View on ClinicalTrials.gov

Polycolistin E Sodium Mesylate Combined With Intravenous Atomization for Carbapenem Resistant Gram-negative Bacteria in Pulmonary Infection

PHASE4Enrolling by invitationINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Lung Infection Bacterial

Interventions

DRUG

Intravenously atomized polycolistin E sodium mesylate

To explore the therapeutic effect of CMS combined with intravenous atomization in patients with carbapenem resistant gram-negative bacteria in lung infection.

Trial Locations (1)

315040

The First Affiliated Hospital of Ningbo University, Ningbo

All Listed Sponsors

lead

First Affiliated Hospital of Ningbo University

NETWORK